Upregulation of C-mip is closely related to podocyte dysfunction in membranous nephropathy

Kidney International

Volumn 83, Issue 3, 2013, Pages 414-425

  Sendeyo, Kelhia ^a,b   Audard, Vincent ^a,b,c   Zhang, Shao Yu ^a,b,c   Fan, Qingfeng ^a,b   Bouachi, Khedidja ^a,b,c   Ollero, Mario ^a,b   Rucker Martin, Catherine ^d,e   Gouadon, Elodie ^d,e   Desvaux, Dominique ^a,b,c   Bridoux, Franck ^f   Guellaën, Georges ^a,b   Ronco, Pierre ^g,h   Lang, Philippe ^a,b,c,i   Pawlak, Andre ^a,b   Sahali, Djillali ^a,b,c,i  

^a INSERM U955   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f University of Poitiers   (France)

^g INSERM   (France)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ Institut Francilien de Recherche en Néphrologie et Transplantation   (France)

Author keywords

glomerular disease; Heymann nephritis; membranous nephropathy; nephrotic syndrome; pathophysiology of renal disease and progression

Indexed keywords

C MAF INDUCING PROTEIN; CYCLOSPORIN A; DEATH ASSOCIATED PROTEIN KINASE; INTEGRIN LINKED KINASE; MEGALIN POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN; SYNAPTOPODIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C MIP GENE; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE OVEREXPRESSION; GLOMERULUS; HEYMANN NEPHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE TYPE HEYMANN NEPHRITIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEINURIA; RAT; TRANSGENIC MOUSE; UPREGULATION;

EID: 84874658636     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.426     Document Type: Article

References (44)

1. Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: From Heymann nephritis to alloimmunization. J Am Soc Nephrol 2005; 16: 1205-1213
2. Imai H, Hamai K, Komatsuda A et al. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 1997; 51: 270-276
3. Beck LH Jr, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21
4. Prunotto M, Carnevali ML, Candiano G et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 21: 507-519
5. Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003; 23: 324-332
6. Heymann W, Hackel DB, Harwood S et al. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med 1959; 100: 660-664
7. Ronco P, Debiec H. Target antigens and nephritogenic antibodies in membranous nephropathy: Of rats and men. Semin Immunopathol 2007; 29: 445-458
8. Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci USA 1982; 79: 5557-5561
9. Kerjaschki D, Farquhar MG. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 1983; 157: 667-686
10. Debiec H, Guigonis V, Mougenot B et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053-2060
11. Debiec H, Nauta J, Coulet F et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 2004; 364: 1252-1259
12. Salant DJ, Belok S, Madaio MP et al. A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 1980; 66: 1339-1350
13. Yuan H, Takeuchi E, Taylor GA et al. Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol 2002; 13: 946-956
14. Saran AM, Yuan H, Takeuchi E et al. Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy. Kidney Int 2003; 64: 2072-2078
15. Nakatsue T, Koike H, Han GD et al. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int 2005; 67: 2239-2253
16. Reiser J, Polu KR, Moller CC et al. TRPC6 is a glomerular slit diaphragmassociated channel required for normal renal function. Nat Genet 2005; 37: 739-744
17. Doublier S, Ruotsalainen V, Salvidio G et al. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 2001; 158: 1723-1731
18. Moller CC, Wei C, Altintas MM et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 2007; 18: 29-36
19. Cunningham PN, Quigg RJ. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol 2005; 16: 1214-1222
20. Couser WG. Pathogenesis of glomerular damage in glomerulonephritis. Nephrol Dial Transplant 1998; 13: 10-15
21. Leenaerts PL, Hall BM, Van Damme BJ et al. Active Heymann nephritis in complement component C6 deficient rats. Kidney Int 1995; 47: 1604-1614
22. Spicer ST, Tran GT, Killingsworth MC et al. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats. J Immunol 2007; 179: 172-178
23. Ronco P, Debiec H. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. J Am Soc Nephrol 2010; 21: 564-569
24. Sahali D, Pawlak A, Valanciute A et al. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 2002; 13: 1238-1247
25. Zhang SY, Kamal M, Dahan K et al. c-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal 2010; 3: Ra39
26. Asanuma K, Yanagida-Asanuma E, Faul C et al. Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol 2006; 8: 485-491
27. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L et al. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrinlinked protein kinase. Nature 1996; 379: 91-96
28. Teixeira Vde P, Blattner SM, Li M et al. Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 2005; 67: 514-523
29. Puthalakath H, Huang DC, O'Reilly LA et al. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 1999; 3: 287-296
30. Wang WJ, Kuo JC, Yao CC et al. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol 2002; 159: 169-179
31. Wiggins RC. The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 2007; 71: 1205-1214
32. Honkanen E, von Willebrand E, Koskinen P et al. Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: Relationships to clinical course. Am J Kidney Dis 2003; 42: 1139-1148
33. Uchida K, Suzuki K, Iwamoto M et al. Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int 2008; 73: 926-932
34. Ohashi T, Uchida K, Asamiya Y et al. Phosphorylation status of nephrin in human membranous nephropathy. Clin Exp Nephrol 14: 51-55
35. Yu D, Petermann A, Kunter U et al. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005; 16: 1733-1741
36. Ambalavanan S, Fauvel JP, Sibley RK et al. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. J Am Soc Nephrol 1996; 7: 290-298
37. Blume C, Heise G, Hess A et al. Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat. Nephron Exp Nephrol 2005; 100: E104-e112
38. Faul C, Donnelly M, Merscher-Gomez S et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008; 14: 931-938
39. Kretzler M, Teixeira VP, Unschuld PG et al. Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J 2001; 15: 1843-1845
40. Wu C, Dedhar S. Integrin-linked kinase (ILK) and its interactors: A new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 2001; 155: 505-510
41. Ory V, Fan Q, Hamdaoui N et al. c-mip down-regulates NF-kappaB activity and promotes apoptosis in podocytes. Am J Pathol 2012; 180: 2284-2292
42. Mundel P, Reiser J, Zuniga Mejia Borja A et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258
43. Aaltonen KE, Ebbesson A, Wigerup C et al. Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue -optimization for genome wide array analyses. BMC Res Notes 2011; 4: 69
44. Audard V, Zhang SY, Copie-Bergman C et al. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes. Blood 2010; 115: 3756-3762